Cognosec AB (Publ): Level 1 ADR filing accepted by SEC
- Cognosec AB Level 1 American Depositary Receipt (’ADR’) Registration Statement accepted by the United States Securities and Exchange Commission (’SEC’)
- BNY Mellon acts as Depositary Bank
- Ticker CYBNY
- ADRs enable United States-based investors to own some of the world’s leading companies including non-US based stocks
- Cognosec AB’s stock on Nasdaq First North available for trading to US-based investors
London, United Kingdom, February 6th, 2018 - Cognosec AB announced today that its Registration Statement has been accepted for a Level 1 ADR program.
The Registration Statement was filed on 26th January 2018 on Form F-6 under the Securities Act of 1933 for American Depositary shares with the SEC relating to the establishment of a Level 1 ADR issuance program.
The Bank of New York Mellon (’BNY Mellon’) acts as the Company`s depositary bank.
The Company’s ticker under the ADR program is CYBNY, CUSIP 19244V107.The ratio (DR:ORD) is 1:10. This program became effective today allowing United States-based investors to participate in Cognosec AB stock.
The popularity of sponsored Level 1 ADRs continues to grow and at the end of 2017, there were ADR programs for issuers from over 50 countries in operation. ADRs allow US-based investors to own foreign companies without the complexity of buying, holding and selling ordinary shares or other cross-border products.
ADRs require no additional disclosure obligations beyond those that are required in home markets and offer a much broader and more diversified investor access which may improve liquidity.
“The ADR program will offer enhanced visibility for Cognosec’s products and services in the US market and will also allow planned expansion into the region providing new US-based employees with the ability to invest more easily in the Group,” said Kobus Paulsen, Cognosec AB’s Chairman.
There are over 1,200 active institutional investors invested in Level 1 ADRs targeting GARP, Growth, Value, Deep Value and Aggressive growth investment styles.
The investor benefits from familiar trade and settlement procedures, portfolio diversification, the potential for inclusion of the ADRs within their Exchange Traded Fund portfolios and Separately Managed Accounts and the convenience of being quoted and having dividends paid directly in United States dollars.
BNY Mellon holds the market share of sponsored ADR programs. There are currently 680 Level 1 ADR programs including Axa, Bayer, Banco do Brasil, BMW and Burberry. ADRs, under Rule 12G3-2(B) are exempt from full SEC registration and reporting requirements under the Exchange Act of 1934. This exemption is available without any action by the company provided that Cognosec maintains a primary listing for its shares outside of the US.
These securities may now be sold and offers to buy may be accepted as the registration statement has become effective.
Certified Adviser: Mangold Fondkommission AB is the Company`s Certified Adviser.
Telephone: +46 (0)8 5030 1550
FOR FURTHER INFORMATION, PLEASE CONTACT:
Tim Metcalfe / Miles Nolan IR-contacts, Cognosec AB
Telephone: +44 (0)203 934 6630
This information is information that Cognosec AB is obliged to make public, pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 6th February, 2018, at 14:00 CET.
Cognosec AB (publ) is engaged in providing cyber resilience solutions and in the prevention of cyber attacks. The business conducts international operations from offices in Sweden, South Africa, the UK, Kenya, Germany, Austria and the United Arab Emirates. Listed on Nasdaq First North (COGS.ST), Cognosec delivers services and bespoke technologies to enhance public and private sector organisations` protections against unwanted intrusions and designs holistic, organisation-wide solutions to prevent diverse and increasing forms of information and identity theft. Cognosec had revenues of EUR14.64m in 2016 and employed 139 personnel at the end of Q4 2017. For further information, please visit www.cognosec.se.